Intravenous immune globulin: Difference between revisions
From IDWiki
(Created page with "== Dosing == {| class="wikitable" !Indication !Dose and Duration |- |Fetal/neonatal alloimmune thrombocytopenia | |- |Hemolytic disease of the fetus and newborn |0.5 g/kg over...") |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 4: | Line 4: | ||
!Dose and Duration |
!Dose and Duration |
||
|- |
|- |
||
|Fetal/neonatal alloimmune thrombocytopenia |
|Fetal/neonatal alloimmune thrombocytopenia, maternal |
||
|up to 2 g/kg weekly starting at 12-16 weeks gestation if previous fetus with intracranial hemorrhage, of up to 1 g/kg weekly starting at 20-26 weeks gestation otherwise |
|||
| |
|- |
||
|Fetal/neonatal alloimmune thrombocytopenia, infant |
|||
|1 g/kg and reassess |
|||
|- |
|- |
||
|Hemolytic disease of the fetus and newborn |
|Hemolytic disease of the fetus and newborn |
||
|0.5 g/kg over 4 hours |
|0.5 g/kg over 4 hours |
||
|- |
|- |
||
|Immune thrombocytopenia, adult, acute |
|[[Immune thrombocytopenia]], adult, acute |
||
|1 g/kg as a single dose; repeat if platelets do not increase by at least 30 |
|1 g/kg as a single dose; repeat if platelets do not increase by at least 30 |
||
|- |
|- |
||
|Immune thrombocytopenia, adult, chronic |
|[[Immune thrombocytopenia]], adult, chronic |
||
|1-2 g/kg, as directed by a hematologist |
|1-2 g/kg, as directed by a hematologist |
||
|- |
|- |
||
|Immune thrombocytopenia, pediatric |
|[[Immune thrombocytopenia]], pediatric |
||
|0.8 to 1 mg/kg as a single dose; can be repeated if no response |
|0.8 to 1 mg/kg as a single dose; can be repeated if no response |
||
|- |
|- |
Latest revision as of 19:04, 8 April 2022
Dosing
Indication | Dose and Duration |
---|---|
Fetal/neonatal alloimmune thrombocytopenia, maternal | up to 2 g/kg weekly starting at 12-16 weeks gestation if previous fetus with intracranial hemorrhage, of up to 1 g/kg weekly starting at 20-26 weeks gestation otherwise |
Fetal/neonatal alloimmune thrombocytopenia, infant | 1 g/kg and reassess |
Hemolytic disease of the fetus and newborn | 0.5 g/kg over 4 hours |
Immune thrombocytopenia, adult, acute | 1 g/kg as a single dose; repeat if platelets do not increase by at least 30 |
Immune thrombocytopenia, adult, chronic | 1-2 g/kg, as directed by a hematologist |
Immune thrombocytopenia, pediatric | 0.8 to 1 mg/kg as a single dose; can be repeated if no response |
Post-transfusion purpura | up to 2 g/kg divided over 2 to 5 consecutive days; repeat if necessary |
Pemphigus vulgaris | 2 g/kg divided over 2 to 5 days every 4 weeks, then every 6 weeks after 6 months of therapy |
Juvenile idiopathic inflammatory myopathy | 2 g/kg initial divided over 2 days as initial dose, followed by maintenance dose of up to 2 g/kg total |
Kawasaki disease | 2 g/kg for 1 day; can be repeated if no response |
Idiopathic inflammatory myopathy, including dermatomyositis and polymyositis | up to 2 g/kg over 2 days monthly for 3 to 6 months, then continued at decreasing freuqncy over 2 years |
Primary and secondary immunodeficiency, adult | 0.4 to 0.6 g/kg every 3 to 4 weeks |
Primary and secondary immunodeficiency, pediatric | 0.3 to 0.6 g/kg every 3 to 4 weeks, targetting tough of 700 mg/dL |
Hematopoietic stem cell transplant in primary immunodeficiency | 0.4-0.6 g/kg every 3 to 4 weeks |
Kidney transplant from living donor to whom the patient is sensitized | 2 g/kg monthly for 4 months |
Pre-transplant heart | up to 1 g/kg monthly until transplant |
Peri-transplant heart, lung, kidney, or pancreas | 1 g/kg in divided doses with a course of plasmapheresis |
Post-transplant, acute | 1 g/kg/dose, can be divided if also getting plasmaphereesis |
Post-transplant, chronic | 1 g/kg monthly |
Streptococcal toxic shock syndrome | 1 g/kg on day one follower by 0.5 mg/kg daily for 2 days, or 0.15 g/kg daily for 5 days |
Staphylococcal toxic shock syndrome | 1 g/kg on day one follower by 0.5 mg/kg daily for 2 days, or 0.15 g/kg daily for 5 days |